People taking Zepbound lose an average of 15% to 21% of their body weight over about 72 weeks, depending on their dose. For someone who weighs 250 pounds, that translates to roughly 37 to 52 pounds. These numbers come from large clinical trials, and individual results vary, but the averages give a realistic picture of what to expect.
Average Weight Loss by Dose
Zepbound is available in three maintenance doses, and weight loss scales with each one. In the largest clinical trial (SURMOUNT-1), participants who took the medication for 72 weeks (about a year and a half) lost the following percentages of their starting body weight:
- 5 mg dose: 15% average body weight loss
- 10 mg dose: 19.5% average body weight loss
- 15 mg dose: 20.9% average body weight loss
The placebo group in the same trial lost just 3.1%, which reflects what diet and exercise alone typically accomplish in a structured clinical setting. That gap highlights how much of the weight loss comes from the medication itself. A second study found slightly lower numbers at the 10 mg and 15 mg doses (12.8% and 14.7%), likely because participants in that trial had type 2 diabetes, which can make weight loss harder.
What That Looks Like in Pounds
Percentages can feel abstract, so here’s a rough translation. At the highest dose, someone starting at 200 pounds could expect to lose around 42 pounds on average. At 300 pounds, that same 21% works out to about 63 pounds. The 5 mg dose, which produces smaller but still significant losses, would mean roughly 30 pounds for a 200-pound person or 45 pounds for someone at 300.
These are averages. Some people lose considerably more, and some lose less. But even the lowest maintenance dose delivers weight loss that was nearly impossible to achieve with older medications.
How Zepbound Compares to Wegovy
The most common comparison is with Wegovy (semaglutide), the other major injectable weight loss medication. A head-to-head study settled this directly: participants on Zepbound 10 mg or 15 mg lost an average of 20.2% of their body weight, while those on Wegovy lost 13.7% over a similar timeframe. That’s roughly a 6.5 percentage point advantage for Zepbound, which for a 250-pound person translates to about 16 extra pounds lost.
The difference comes down to biology. Wegovy activates one gut hormone pathway (GLP-1), while Zepbound activates two: GLP-1 and a second pathway called GIP. Both reduce appetite and slow digestion, but the dual action appears to produce stronger effects on weight and blood sugar regulation. Research suggests the GIP pathway also improves how the body responds to insulin through a mechanism that’s separate from the weight loss itself.
How Quickly the Weight Comes Off
You won’t start at a full dose. Zepbound begins at 2.5 mg once weekly for the first four weeks, which is a starter dose designed to let your body adjust. That dose isn’t approved as a maintenance treatment. After four weeks, you move to 5 mg, and from there your prescriber can increase the dose in 2.5 mg steps, waiting at least four weeks between each bump. Reaching the maximum 15 mg dose takes a minimum of about five months if you increase at every opportunity.
Weight loss tends to follow the dose escalation. Most people see modest losses in the first month or two, with the pace picking up as the dose increases. The clinical trials measured outcomes at 72 weeks, and the weight loss curves in those studies show continued progress through most of that period before gradually leveling off. There’s no single “big month” where the weight drops all at once. It’s a steady process that rewards patience.
What Happens If You Stop
This is the part many people don’t hear about upfront. A study called SURMOUNT-4 tracked what happened when participants stopped taking Zepbound after 36 weeks and switched to a placebo. The results were striking: one year after stopping, 82% of participants had regained more than a quarter of the weight they’d lost. About a third regained 50% to 75% of the lost weight, and roughly a quarter gained back 75% or more.
Only a small group, about 17% of participants, managed to keep most of the weight off after stopping. This pattern isn’t unique to Zepbound. It reflects how the body’s appetite and metabolism regulation systems reassert themselves once the medication is removed. For most people, Zepbound works best as an ongoing treatment rather than a short-term intervention.
Who Can Get a Prescription
Zepbound is FDA-approved for adults who meet one of two criteria:
- BMI of 30 or higher, which qualifies as obesity
- BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or cardiovascular disease
The approval also specifies that Zepbound should be used alongside a reduced-calorie diet and increased physical activity. In practice, the medication makes both of those things easier because it significantly reduces hunger and food cravings. Many people report that the constant mental noise around food quiets down within the first few weeks, which is often described as the most life-changing part of the experience, separate from the number on the scale.
Setting Realistic Expectations
The 15% to 21% average weight loss is genuinely impressive by the standards of obesity medicine, but it helps to understand what “average” means here. Some participants in trials lost 25% or more of their body weight. Others lost 10% or less. Your starting weight, metabolic health, dose tolerance, diet, activity level, and genetics all play a role. People with type 2 diabetes tend to lose less weight on the same doses, as shown by the difference between the two major trials.
Even a 10% loss in body weight produces meaningful health improvements: lower blood pressure, better blood sugar control, reduced joint pain, and improved sleep quality. If you land below the trial averages, the health benefits are still substantial. The percentages in headlines represent the ceiling of what large groups achieved on average, not a minimum threshold for the medication to be “working.”